Login

Megan Baldwin, CEO, Opthea Ltd 00:00:00

Share On Facebook Share On Twitter

Opthea with Proactive at the ASX Small and Mid-Cap Conference

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Ben McMillan, CIO and founder of IDX Digital Assets, discusses market insights in an interview with CNBC.
00:10:00
From Engineer Aspirations to Financial Leadership: The Journey of James Cracchiolo |James Cracchiolo, CEO , Ameriprise Financial Inc.
00:10:00
For digital mining solutions, Orica introduces Axis Mining Technology. | Shane Munyard, CEO, Axis Mining Technology Pty Ltd. (TS)
00:10:00
That was a thorough conversation covering a lot of ground about Global Whole Health Partners and their products.
00:10:00
Innovating Pharma: Lars Minor Discusses Newbury’s Product Rollout Plans | Lars Minor, CEO , Polymetals Resources Ltd.
00:10:00
Path to Retirement: Reaching and Relishing Your Golden Years | Matthew Kelley - President of Gold Medal Waters, Inc.
00:10:00
David Bramhill on Union Jack Oil's Strategy Amidst UK Challenges and US Opportunities | David Bramhill, Executive Chairman, Union Jack Oil Plc.
00:10:00
Focus on proving all of the on-ramps that founders|Antoine Poirson,Partner,Antler
00:10:00
Calibre Mining's Progress and Future Plans: An Interview with Dave at the One-to-One Conference in London
00:10:00
Cemex CEO, Lic. Fernando González Olivieri, Shares Entrepreneurial Insights | Fernando Angel Angel Gonzalez Olivieri - CEO of Cemex
00:10:00
Taking the Leap: Louis Toenjes on Leading St. Amand in Craft Spirits | Daniel Yerger - President of MY Wealth Planners
00:10:00
Global Market Insights and Investment Strategies with Stephen Gilmore, CIO of New Zealand Super Fund | Capital Allocators Manager Meetings

© 2026 Nehu